|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01858 CHUNLI MEDICAL
Nominal 
8.060 +0.070 (+0.876%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 380,131 | -29.697% | 540,707 | 571,392 | 482,632 | 406,990 |
| Cost of Sales | -- | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (6,353) | -16.208% | (7,582) | (12,817) | (10,238) | (4,859) | |
| Profit / (Loss) on Disposal | 39 | -- | -- | 25 | 8 | 0 | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 83,070 | -40.038% | 138,537 | 172,397 | 182,250 | 140,686 | |
| Taxation | (4,109) | -67.264% | (12,552) | (15,415) | (26,695) | (23,853) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 65 | -29.052% | 92 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 79,026 | -37.319% | 126,077 | 156,982 | 155,555 | 116,833 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (9,012) | 80.469% | (4,994) | (5,778) | (5,350) | 4,317 |
| Depreciation & Amortisation | 18,650 | 15.298% | 16,176 | 13,287 | 8,727 | -- |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | 21.000 | -36.364% | 33.000 | 41.000 | 45.000 | 34.000 |
| DPS (cts) | 8.300 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | 39.524% | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 7.346 | -- | 7.106 | 6.704 | 3.571 | 2.640 |
| Remarks: | Real time quote last updated: 25/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 79,026,079 |
| %Change | -37.319% |
| EPS / (LPS) | RMB 0.210 |
| NBV Per Share (¥) | RMB 7.346 |